
    
      Participants with treatment resistant depression will be recruited to participate in a
      12-week clinical trial on the effects of adjunct moderate-intensity exercise versus usual
      care. Primary outcome measure will be reduction in baseline scores on Hamilton Depression
      Rating Scale (17 item). Secondary outcome measure will include reduction in baseline scores
      of clinical global impression severity, pittsburgh sleep quality index global score, scores
      on beck depression inventory, and improvement in actigraphic sleep.
    
  